Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics
MMSI Price/Volume Stats
Current price | $85.24 | 52-week high | $85.62 |
Prev. close | $84.42 | 52-week low | $50.46 |
Day low | $84.06 | Volume | 240,300 |
Day high | $85.62 | Avg. volume | 258,948 |
50-day MA | $80.15 | Dividend yield | N/A |
200-day MA | $69.80 | Market Cap | 4.90B |
MMSI Stock Price Chart Interactive Chart >
MMSI POWR Grades
- Growth is the dimension where MMSI ranks best; there it ranks ahead of 99.5% of US stocks.
- MMSI's strongest trending metric is Quality; it's been moving down over the last 179 days.
- MMSI ranks lowest in Quality; there it ranks in the 55th percentile.
MMSI Stock Summary
- MMSI's went public 31.26 years ago, making it older than 83.95% of listed US stocks we're tracking.
- MMSI's current price/earnings ratio is 54.67, which is higher than 89.8% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for MMSI is currently 39.62, higher than 89.88% of US stocks with positive operating cash flow.
- Stocks that are quantitatively similar to MMSI, based on their financial statements, market capitalization, and price volatility, are INTT, LMAT, KVHI, BDC, and SHYF.
- Visit MMSI's SEC page to see the company's official filings. To visit the company's web site, go to www.merit.com.
MMSI Valuation Summary
- MMSI's price/sales ratio is 4; this is 21.57% lower than that of the median Healthcare stock.
- Over the past 243 months, MMSI's EV/EBIT ratio has gone up 35.4.
Below are key valuation metrics over time for MMSI.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MMSI | 2023-05-23 | 4.0 | 4.0 | 54.8 | 47.8 |
MMSI | 2023-05-22 | 4.1 | 4.1 | 57.3 | 50.0 |
MMSI | 2023-05-19 | 4.1 | 4.2 | 57.4 | 50.1 |
MMSI | 2023-05-18 | 4.1 | 4.1 | 57.0 | 49.7 |
MMSI | 2023-05-17 | 4.1 | 4.1 | 57.0 | 49.7 |
MMSI | 2023-05-16 | 4.1 | 4.1 | 57.1 | 49.8 |
MMSI Growth Metrics
- The 2 year revenue growth rate now stands at 10.12%.
- Its 3 year revenue growth rate is now at 19.95%.
- Its 5 year net income to common stockholders growth rate is now at -112.75%.

The table below shows MMSI's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 1,150.981 | 114.291 | 74.516 |
2022-09-30 | 1,136.058 | 132.098 | 61.728 |
2022-06-30 | 1,115.904 | 121.585 | 58.423 |
2022-03-31 | 1,101.253 | 124.009 | 48.041 |
2021-12-31 | 1,074.751 | 147.231 | 48.454 |
2021-09-30 | 1,054.263 | 138.331 | 43.219 |
MMSI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MMSI has a Quality Grade of C, ranking ahead of 57.58% of graded US stocks.
- MMSI's asset turnover comes in at 0.622 -- ranking 67th of 186 Medical Equipment stocks.
- OSUR, CNMD, and ESMC are the stocks whose asset turnover ratios are most correlated with MMSI.
The table below shows MMSI's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.622 | 0.436 | 0.033 |
2021-03-31 | 0.578 | 0.422 | 0.008 |
2020-12-31 | 0.567 | 0.416 | -0.003 |
2020-09-30 | 0.559 | 0.417 | -0.018 |
2020-06-30 | 0.551 | 0.419 | -0.019 |
2020-03-31 | 0.571 | 0.432 | 0.005 |
MMSI Price Target
For more insight on analysts targets of MMSI, see our MMSI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $76.22 | Average Broker Recommendation | 1.44 (Moderate Buy) |
Merit Medical Systems, Inc. (MMSI) Company Bio
Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.
Latest MMSI News From Around the Web
Below are the latest news stories about MERIT MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate MMSI as an investment opportunity.
Revvity (RVTY) Launches New System for Autoimmune DiagnosticsRevvity's (RVTY) EUROIMMUN launches UNIQO 160, a new automated system for autoimmune disease diagnostics using indirect immunofluorescence test. |
Thermo Fisher's (TMO) Unveils Orbitrap Astral SpectrometerThermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories. |
Hologic (HOLX) Stock Up 5.6% YTD: Will the Rally Continue?The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth. |
Here's Why You Should Hold on to Align Technology (ALGN) NowInvestors are optimistic about Align Technology (ALGN) owing to expanding work-flow options of its leading iTero scanners. |
Illumina's (ILMN) New AI Tool to Predict Genomics DiseaseIllumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software. |
MMSI Price Returns
1-mo | 0.76% |
3-mo | 27.09% |
6-mo | 17.65% |
1-year | 43.02% |
3-year | 88.33% |
5-year | 73.08% |
YTD | 20.70% |
2022 | 13.35% |
2021 | 12.23% |
2020 | 77.80% |
2019 | -44.06% |
2018 | 29.19% |
Continue Researching MMSI
Want to do more research on Merit Medical Systems Inc's stock and its price? Try the links below:Merit Medical Systems Inc (MMSI) Stock Price | Nasdaq
Merit Medical Systems Inc (MMSI) Stock Quote, History and News - Yahoo Finance
Merit Medical Systems Inc (MMSI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...